OTCMKTS:ANTB

(ANTB) (ANTB) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$0.81
$0.83
50-Day Range
N/A
52-Week Range
$0.75
$1.25
Volume
2,100 shs
Average Volume
8,783 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About (ANTB)

Rezolute, Inc. is biopharmaceutical company, which engages in the development of drug therapies for patients with metabolic and orphan diseases. Its products portfolio include RZ358-Phase 2, an antibody for the ultra-orphan indication of congenital hyperInsulinism; AB101-Phase 1, a once-weekly injectable basal insulin; and RZ402 which targets diabetic macular edema. The company was founded by Nevan Charles Elam, Ho Young Huh, and Sankaram Mantripragada on July 26, 2010 and is headquartered in Redwood City, CA.

ANTB Stock News Headlines

World’s biggest multibillionaire investor is buying THIS by the ton [picture]
Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.
Aerodrom Nikola Tesla ad AERO
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty.
Remarkable Roman ruins still standing
Beautiful Roman ruins everyone should see
Staggering Roman ruins still standing
See More Headlines
Receive ANTB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (ANTB) and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Internet Software & Services
Sub-Industry
N/A
Current Symbol
OTCMKTS:ANTB
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

  • Nevan Charles Elam
    President, Chief Executive Officer, CFO & Director
  • Michael Deperro
    Head-Operations
  • Sankaram Mantripragada
    Chief Scientific Officer
  • Erin O’Boyle
    Head-Clinical Operations
  • Davelyn Hood
    Director-Scientific & Patient Affairs

ANTB Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of (ANTB) own?
This page (OTCMKTS:ANTB) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners